196 related articles for article (PubMed ID: 34302730)
1. Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
Ku EJ; Yoo WS; Lee EK; Ahn HY; Woo SH; Hong JH; Chung HK; Park JW
J Clin Endocrinol Metab; 2021 Nov; 106(12):3655-3667. PubMed ID: 34302730
[TBL] [Abstract][Full Text] [Related]
2. Effects of thyroid-stimulating hormone suppression after thyroidectomy for thyroid cancer on bone mineral density in postmenopausal women: a systematic review and meta-analysis.
Kwak D; Ha J; Won Y; Kwon Y; Park S
BMJ Open; 2021 May; 11(5):e043007. PubMed ID: 33986046
[TBL] [Abstract][Full Text] [Related]
3. The risk between thyrotropin suppression and bone mineral density in differentiated thyroid cancer.
Zou Y; Li B; Wang X; Mao J; Zhang Y
Medicine (Baltimore); 2022 Dec; 101(48):e31991. PubMed ID: 36482589
[TBL] [Abstract][Full Text] [Related]
4. Effects of TSH suppressive therapy on bone mineral density (BMD) and bone turnover markers (BTMs) in patients with differentiated thyroid cancer in Northeast China: a prospective controlled cohort study.
Wang S; Wang Y; Zhu L; He L; Lv M; Zhang H; Wang H; Zhang F; Lai Y; Li Y; Shan Z; Teng W
Endocrine; 2023 Jan; 79(1):113-124. PubMed ID: 36089636
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
[TBL] [Abstract][Full Text] [Related]
6. Influence of Thyroid-stimulating Hormone Suppression Therapy on Bone Mineral Density in Patients with Differentiated Thyroid Cancer: A Meta-analysis.
Yoon BH; Lee Y; Oh HJ; Kim SH; Lee YK
J Bone Metab; 2019 Feb; 26(1):51-60. PubMed ID: 30899725
[TBL] [Abstract][Full Text] [Related]
7. Trabecular bone deterioration in differentiated thyroid cancer: Impact of long-term TSH suppressive therapy.
Hawkins Carranza F; Guadalix Iglesias S; Luisa De Mingo Domínguez M; Martín-Arriscado Arroba C; López Álvarez B; Allo Miguel G; Martínez Díaz-Guerra G
Cancer Med; 2020 Aug; 9(16):5746-5755. PubMed ID: 32583973
[TBL] [Abstract][Full Text] [Related]
8. Trabecular bone score in women with differentiated thyroid cancer on long-term TSH-suppressive therapy.
Sousa BÉCA; Silva BC; de Oliveira Guidotti T; Pires MC; Soares MMS; Kakehasi AM
J Endocrinol Invest; 2021 Oct; 44(10):2295-2305. PubMed ID: 33730348
[TBL] [Abstract][Full Text] [Related]
9. Assessment for bone health in patients with differentiated thyroid carcinoma after postoperative thyroid-stimulating hormone suppression therapy: a new fracture risk assessment algorithm.
Jia H; Qu W; Cai X; Li M; Qian Y; Jiang Z; Zhang Z
Front Endocrinol (Lausanne); 2023; 14():1286947. PubMed ID: 38075039
[TBL] [Abstract][Full Text] [Related]
10. The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma.
Moon JH; Jung KY; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Jang HC
Bone; 2016 Feb; 83():104-110. PubMed ID: 26518742
[TBL] [Abstract][Full Text] [Related]
11. Bone-density testing interval and transition to osteoporosis in differentiated thyroid carcinoma patients on TSH suppression therapy.
Park H; Park J; Yoo H; Kim S; Koh JH; Jee JH; Min YK; Chung JH; Kim TH; Kang M; Kim SW
Clin Endocrinol (Oxf); 2022 Jul; 97(1):130-136. PubMed ID: 35174522
[TBL] [Abstract][Full Text] [Related]
12. The Effect of TSH Suppression on Vertebral Trabecular Bone Scores in Patients With Differentiated Thyroid Carcinoma.
Moon JH; Kim KM; Oh TJ; Choi SH; Lim S; Park YJ; Park DJ; Jang HC
J Clin Endocrinol Metab; 2017 Jan; 102(1):78-85. PubMed ID: 27754806
[TBL] [Abstract][Full Text] [Related]
13. Measurements of Bone Health after Thyroid-Stimulating Suppression Therapy in Postmenopausal Women with Differentiated Thyroid Carcinoma: Bone Mineral Density versus the Trabecular Bone Score.
Chung CW; Choi HS; Kong SH; Park YJ; Park DJ; Ahn HY; Cho SW
J Clin Med; 2021 May; 10(9):. PubMed ID: 34063726
[TBL] [Abstract][Full Text] [Related]
14. Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.
Baqi L; Payer J; Killinger Z; Hruzikova P; Cierny D; Susienkova K; Langer P
Endocr Regul; 2010 Apr; 44(2):57-63. PubMed ID: 20429634
[TBL] [Abstract][Full Text] [Related]
15. Bone Mineral Density in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma: A Longitudinal Follow-Up Study.
Dekker BL; Muller Kobold AC; Brouwers AH; Williams GR; Nies M; Klein Hesselink MS; van der Horst-Schrivers ANA; Havekes B; van den Heuvel-Eibrink MM; van der Pal HJH; Plukker JTM; Ronckers CM; van Santen HM; Burgerhof JGM; Corssmit EPM; Netea-Maier RT; Peeters RP; van Dam EWCM; Boot AM; Tissing WJE; Bocca G; Links TP
Thyroid; 2021 Nov; 31(11):1707-1714. PubMed ID: 34514857
[No Abstract] [Full Text] [Related]
16. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy.
De Mingo Dominguez ML; Guadalix Iglesias S; Martin-Arriscado Arroba C; López Alvarez B; Martínez Diaz-Guerra G; Martinez-Pueyo JI; Ferrero Herrero E; Hawkins Carranza F
Endocrine; 2018 Oct; 62(1):166-173. PubMed ID: 30014437
[TBL] [Abstract][Full Text] [Related]
17. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
Biondi B; Cooper DS
Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
[TBL] [Abstract][Full Text] [Related]
18. TSH-suppressive therapy can reduce bone mineral density in patients with differentiated thyroid carcinoma: a meta-analysis.
Wang MY; Han ZQ; Gong XW; Li Q; Ma J
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):922-929. PubMed ID: 32016999
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.
Guo CY; Weetman AP; Eastell R
Clin Endocrinol (Oxf); 1997 Mar; 46(3):301-7. PubMed ID: 9156039
[TBL] [Abstract][Full Text] [Related]
20. Effects of levothyroxine therapy on bone mineral density and bone turnover markers in premenopausal women with thyroid cancer after thyroidectomy.
Bin-Hong D; Fu-Man D; Yu L; Xu-Ping W; Bing-Feng B
Endokrynol Pol; 2020; 71(1):15-20. PubMed ID: 31681976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
